<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7273044\results\search\disease\results.xml">
  <result pre="Microbiology and VirologySchool of Medicine, Jiroft University of Medical SciencesJiroftIran[4]," exact="Cancer" post="Research Center, Semnan University of Medical SciencesSemnanIran *Correspondence Majid"/>
  <result pre="Medical SciencesSemnanIran *Correspondence Majid Eslami, Department of Bacteriology and Virology," exact="Cancer" post="Research Center, Semnan University of Medical Sciences, Semnan, Iran."/>
  <result pre=", This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
  <result pre="In late December 2019 in Wuhan, China, several patients with" exact="viral pneumonia" post="were identified as 2019 novel coronavirus (2019â€�nCoV). So far,"/>
  <result pre="late December 2019 in Wuhan, China, several patients with viral" exact="pneumonia" post="were identified as 2019 novel coronavirus (2019â€�nCoV). So far,"/>
  <result pre="based on previous experience with similar viruses such as severe" exact="acute" post="respiratory syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory syndrome coronavirus"/>
  <result pre="on previous experience with similar viruses such as severe acute" exact="respiratory" post="syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory syndrome coronavirus (MERSâ€�CoV),"/>
  <result pre="such as severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV), and Influenza virus. In this article,"/>
  <result pre="as severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV), and Influenza virus. In this article, we"/>
  <result pre="inhibitors such as lopinavir/ritonavir (LPV/r) inhibit the progression of MERSâ€�CoV" exact="disease" post="and can be useful for patients of COVIDâ€�19 and,"/>
  <result pre="on early replication of SARSâ€�CoV. Ribavirin reduces hemoglobin concentrations in" exact="respiratory" post="patients, and remdesivir improves respiratory symptoms. Use of ribavirin"/>
  <result pre="Ribavirin reduces hemoglobin concentrations in respiratory patients, and remdesivir improves" exact="respiratory" post="symptoms. Use of ribavirin in combination with LPV/r in"/>
  <result pre="ribavirin in combination with LPV/r in patients with SARSâ€�CoV reduces" exact="acute" post="respiratory distress syndrome and mortality, which has a significant"/>
  <result pre="in combination with LPV/r in patients with SARSâ€�CoV reduces acute" exact="respiratory" post="distress syndrome and mortality, which has a significant protective"/>
  <result pre="with LPV/r in patients with SARSâ€�CoV reduces acute respiratory distress" exact="syndrome" post="and mortality, which has a significant protective effect with"/>
  <result pre="the addition of corticosteroids. Favipiravir increases clinical recovery and reduces" exact="respiratory" post="problems and has a stronger antiviral effect than LPV/r."/>
  <result pre="In late December 2019 in Wuhan, China, several patients with" exact="viral pneumonia" post="were identified as 2019 novel coronavirus (2019â€�nCoV). So far,"/>
  <result pre="late December 2019 in Wuhan, China, several patients with viral" exact="pneumonia" post="were identified as 2019 novel coronavirus (2019â€�nCoV). So far,"/>
  <result pre="based on previous experience with similar viruses such as severe" exact="acute" post="respiratory syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory syndrome coronavirus"/>
  <result pre="on previous experience with similar viruses such as severe acute" exact="respiratory" post="syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory syndrome coronavirus (MERSâ€�CoV),"/>
  <result pre="such as severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV), and Influenza virus. In patients with"/>
  <result pre="as severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV), Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV), and Influenza virus. In patients with COVIDâ€�19,"/>
  <result pre="inhibitors such as lopinavir/ritonavir (LPV/r) inhibit the progression of MERSâ€�CoV" exact="disease" post="and can be useful for patients of COVIDâ€�19 and,"/>
  <result pre="early replication of SARSâ€�CoV. Favipiravir increases clinical recovery and reduces" exact="respiratory" post="problems and has a stronger antiviral effect than LPV/r."/>
  <result pre="2020;1â€&quot;10. 10.1002/jcp.29785 1 HISTORY Looking at the major pandemics of" exact="respiratory" post="viruses, we are mainly exposed to the influenza virus,"/>
  <result pre="theories predict that the next pandemic of this category of" exact="respiratory" post="infections will occur between 2020 and 2050 and be"/>
  <result pre="predict that the next pandemic of this category of respiratory" exact="infections" post="will occur between 2020 and 2050 and be capable"/>
  <result pre="a human epidemic (Holmes,Â 2013). Seasonal influenza is primarily an" exact="upper" post="respiratory disease that recurs in different forms each year."/>
  <result pre="human epidemic (Holmes,Â 2013). Seasonal influenza is primarily an upper" exact="respiratory" post="disease that recurs in different forms each year. The"/>
  <result pre="epidemic (Holmes,Â 2013). Seasonal influenza is primarily an upper respiratory" exact="disease" post="that recurs in different forms each year. The â€œflu"/>
  <result pre="December 2019 in Wuhan, China, several patients were diagnosed with" exact="viral pneumonia," post="now known as the 2019 novel coronavirus (2019â€�nCoV). Subsequently,"/>
  <result pre="coronavirus (2019â€�nCoV). Subsequently, a large number of cases of the" exact="disease" post="were found to either reside in Wuhan or travel"/>
  <result pre="genomes that appeared in Zhoushan, China, but with the severe" exact="acute" post="respiratory syndromeâ€�related coronavirus (SARSâ€�CoV) and Middle East respiratory syndrome"/>
  <result pre="that appeared in Zhoushan, China, but with the severe acute" exact="respiratory" post="syndromeâ€�related coronavirus (SARSâ€�CoV) and Middle East respiratory syndrome coronavirus"/>
  <result pre="the severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV) coronaviruses, 79% and 50% were similar,"/>
  <result pre="severe acute respiratory syndromeâ€�related coronavirus (SARSâ€�CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV) coronaviruses, 79% and 50% were similar, respectively."/>
  <result pre="to bind the host cell, that contains a diversity of" exact="respiratory" post="epithelial cells, alveolar macrophages, and monocytes. Considering the relatively"/>
  <result pre="bind the host cell, that contains a diversity of respiratory" exact="epithelial" post="cells, alveolar macrophages, and monocytes. Considering the relatively high"/>
  <result pre="SARSâ€�CoVâ€�2 and SARSâ€�CoV RBD to ACE2â€�expressing cells, so inhibiting their" exact="infection" post="to host cells. Therefore, ACE2 also serves as the"/>
  <result pre="improve SARSâ€�CoV RBDâ€�based vaccines for inhibition of SARSâ€�CoVâ€�2 and SARSâ€�CoV" exact="infection" post="(Tai et al.,Â 2020; Wan, Shang, Graham, Baric, &amp;amp;"/>
  <result pre="human SARSâ€�CoV. For example, bat SLâ€�CoVâ€�WIV1 can grow on human" exact="epithelial" post="cells and Vero E6 cells, which is neutralized by"/>
  <result pre="to as 2019â€�nCoV, has recently caused a pandemic scale of" exact="pneumonia" post="in humans and resulted in a huge threat to"/>
  <result pre="to the lungs, which leads to fluid leaking from small" exact="blood vessels" post="in the lungs. The fluid collects in the lungs'"/>
  <result pre="similar viruses such as SARSâ€�CoV, MERSâ€�CoV, influenza virus, and other" exact="viral" post="infections. In this article, we have tried to study"/>
  <result pre="mechanism of action in COVIDâ€�19 Kaletra (lopinavir/ritonavir) Used to treat" exact="HIV infection" post="400â€‰mg/100â€‰mg twice daily Protease inhibitor Chloroquine Inhibit quinone reductase"/>
  <result pre="of action in COVIDâ€�19 Kaletra (lopinavir/ritonavir) Used to treat HIV" exact="infection" post="400â€‰mg/100â€‰mg twice daily Protease inhibitor Chloroquine Inhibit quinone reductase"/>
  <result pre="inhibitor Chloroquine Inhibit quinone reductase 2 that used to treat" exact="malaria" post="infection 200â€‰mg, three times per day during 10 days"/>
  <result pre="Chloroquine Inhibit quinone reductase 2 that used to treat malaria" exact="infection" post="200â€‰mg, three times per day during 10 days Block"/>
  <result pre="infection 200â€‰mg, three times per day during 10 days Block" exact="virus infection" post="by increasing endosomal pH required for virus/cell fusion, interfering"/>
  <result pre="200â€‰mg, three times per day during 10 days Block virus" exact="infection" post="by increasing endosomal pH required for virus/cell fusion, interfering"/>
  <result pre="viruses such as coronaviruses IFNâ€� alpha Used to treat HBV" exact="infection" post="5 million U bid inhalation A broadâ€�spectrum antiviral drug"/>
  <result pre="each time, two times/day Umifenovir (Arbidol) Used to treat influenza" exact="virus infection" post="200â€‰mg each time, three times/day Inhibit viral entry into"/>
  <result pre="time, two times/day Umifenovir (Arbidol) Used to treat influenza virus" exact="infection" post="200â€‰mg each time, three times/day Inhibit viral entry into"/>
  <result pre="treat influenza virus infection 200â€‰mg each time, three times/day Inhibit" exact="viral" post="entry into target cells and stimulate the immune response"/>
  <result pre="stimulate the immune response Oseltamivir (Tamiflu) Used to treat influenza" exact="virus infection" post="75â€‰mg every 12â€‰hr Neuraminidase inhibitors Ribavirin Used to treat"/>
  <result pre="the immune response Oseltamivir (Tamiflu) Used to treat influenza virus" exact="infection" post="75â€‰mg every 12â€‰hr Neuraminidase inhibitors Ribavirin Used to treat"/>
  <result pre="every 12â€‰hr Neuraminidase inhibitors Ribavirin Used to treat RSV infection," exact="hepatitis C," post="and some viral hemorrhagic fevers 500â€‰mg each time, 2â€&quot;3"/>
  <result pre="Ribavirin Used to treat RSV infection, hepatitis C, and some" exact="viral" post="hemorrhagic fevers 500â€‰mg each time, 2â€&quot;3 times/day in combination"/>
  <result pre="A synthetic guanosine nucleoside that interferes with the synthesis of" exact="viral" post="mRNA Teicoplanin A glycopeptide antibiotic that used to treat"/>
  <result pre="mRNA Teicoplanin A glycopeptide antibiotic that used to treat Gramâ€�positive" exact="bacterial infection" post="To inhibit 50% of viruses (IC50) in vitro was"/>
  <result pre="Teicoplanin A glycopeptide antibiotic that used to treat Gramâ€�positive bacterial" exact="infection" post="To inhibit 50% of viruses (IC50) in vitro was"/>
  <result pre="vitro was 1.66â€‰Î¼M Inhibiting the low pH cleavage of the" exact="viral" post="spike protein and the continuation of virus replication cycle"/>
  <result pre="replication cycle Favipiravir (FPV) Used to treat many RNA viruses" exact="infections" post="600â€‰mg twice daily Inhibition of viral RdRp Abbreviations: COVIDâ€�19,"/>
  <result pre="treat many RNA viruses infections 600â€‰mg twice daily Inhibition of" exact="viral" post="RdRp Abbreviations: COVIDâ€�19, coronavirus diseaseâ€�19; HBV, hepatitis B virus;"/>
  <result pre="daily Inhibition of viral RdRp Abbreviations: COVIDâ€�19, coronavirus diseaseâ€�19; HBV," exact="hepatitis" post="B virus; IFNâ€�Î± interferonâ€�Î±; mRNA, messenger RNA; RdRp, RNAâ€�dependent"/>
  <result pre="IFNâ€�Î± interferonâ€�Î±; mRNA, messenger RNA; RdRp, RNAâ€�dependent RNA polymerase; RSV," exact="respiratory" post="syncytial virus; SARSâ€�CoV, severe acute respiratory syndromeâ€�related coronavirus. (C)"/>
  <result pre="RdRp, RNAâ€�dependent RNA polymerase; RSV, respiratory syncytial virus; SARSâ€�CoV, severe" exact="acute" post="respiratory syndromeâ€�related coronavirus. (C) John Wiley &amp;amp; Sons, Ltd.,"/>
  <result pre="RNAâ€�dependent RNA polymerase; RSV, respiratory syncytial virus; SARSâ€�CoV, severe acute" exact="respiratory" post="syndromeâ€�related coronavirus. (C) John Wiley &amp;amp; Sons, Ltd., This"/>
  <result pre="Ltd., This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
  <result pre="2.1.1 Teicoplanin A glycopeptide antibiotic commonly used to treat a" exact="bacterial infection" post="is active against SARSâ€�CoV and is on the list"/>
  <result pre="Teicoplanin A glycopeptide antibiotic commonly used to treat a bacterial" exact="infection" post="is active against SARSâ€�CoV and is on the list"/>
  <result pre="al.,Â 2020). This antibiotic is commonly used to treat Gramâ€�positive" exact="bacterial infections," post="especially staphylococcal and streptococcal infections, which are effective against"/>
  <result pre="commonly used to treat Gramâ€�positive bacterial infections, especially staphylococcal and" exact="streptococcal infections," post="which are effective against viruses such as Ebola, influenza"/>
  <result pre="are effective against viruses such as Ebola, influenza virus, flavivirus," exact="hepatitis C" post="virus, HIV, and on coronaviruses such as MERSâ€�CoV and"/>
  <result pre="which is blocked by the low pH cleavage of the" exact="viral" post="spike protein by cathepsin L in the late endosomes,"/>
  <result pre="in the late endosomes, thus blocking the release of the" exact="viral" post="RNA genome and the virus replication cycle (Cathepsin L"/>
  <result pre="(Plaquenil) Firstâ€�line treatments used for prophylaxis of malaria, amebiasis, and" exact="autoimmune diseases" post="such as rheumatoid arthritis, systemic sclerosis, and systemic lupus"/>
  <result pre="for prophylaxis of malaria, amebiasis, and autoimmune diseases such as" exact="rheumatoid arthritis," post="systemic sclerosis, and systemic lupus erythematosus inhibit the proliferation"/>
  <result pre="of malaria, amebiasis, and autoimmune diseases such as rheumatoid arthritis," exact="systemic" post="sclerosis, and systemic lupus erythematosus inhibit the proliferation of"/>
  <result pre="and autoimmune diseases such as rheumatoid arthritis, systemic sclerosis, and" exact="systemic" post="lupus erythematosus inhibit the proliferation of several DNA and"/>
  <result pre="autoimmune diseases such as rheumatoid arthritis, systemic sclerosis, and systemic" exact="lupus erythematosus" post="inhibit the proliferation of several DNA and RNAâ€�containing viruses,"/>
  <result pre="analog introduced by Gilead Sciences in 2017 to treat Ebola" exact="virus infection" post="and shown to have antiviral activity against Marburg virus,"/>
  <result pre="introduced by Gilead Sciences in 2017 to treat Ebola virus" exact="infection" post="and shown to have antiviral activity against Marburg virus,"/>
  <result pre="and shown to have antiviral activity against Marburg virus, parainfluenza" exact="type 3" post="virus, Nipah virus, Hendra virus, and measles, mumps, and"/>
  <result pre="Hendra virus, and measles, mumps, and Pneumoviridae (such as a" exact="respiratory" post="syncytial virus [RSV]) in vitro. It is a prodrug"/>
  <result pre="SARSâ€�CoVâ€�2. Remdesivir is a metabolically active form (GSâ€�441524) that affects" exact="viral" post="RNA polymerase and prevents the spread of the virus"/>
  <result pre="the spread of the virus and reduces the production of" exact="viral" post="RNA. It has a similar structure to tenofovir alafenamide,"/>
  <result pre="a nucleotide analog of adenosine 5â€�monophosphate with antiviral activity against" exact="hepatitis" post="B virus and HIV (Lo et al.,Â 2017; Pedersen"/>
  <result pre="a SARSâ€�CoVâ€�infected mouse, remdesivir administration significantly reduced the rate of" exact="viral" post="load in the lungs, and the virus titer decreased"/>
  <result pre="on Day 4 or 5 postinfection, indicating that remdesivir improved" exact="respiratory" post="symptoms in the laboratory model (T. Sheahan et al.,Â"/>
  <result pre="model (rhesus macaque), the therapeutic effect of remdesivir on MERSâ€�CoV" exact="infection" post="was investigated, with remdesivir being injected 3â€‰hr before virus"/>
  <result pre="in combination with ritonavir to treat patients with AIDS and" exact="HIV infection." post="Lopinavir is a potent and highly specific inhibitor of"/>
  <result pre="et al. (2020), the effect of lopinavir plus ritonavir on" exact="adult" post="patients with COVIDâ€�19 in China showed that concomitant use"/>
  <result pre="(2020) in combination with lopinavir/ritonavir (LPV/r) and no decrease in" exact="viral" post="titers was observed in patients with COVIDâ€�19 but was"/>
  <result pre="more research is needed within a few days of the" exact="disease" post="to determine if better results can be obtained (Lim"/>
  <result pre="with this drug, complications such as digestive adverse effect and" exact="hypokalemia" post="should be considered by physicians (Liu et al.,Â 2020)."/>
  <result pre="influenza A and B and is also known to inhibit" exact="hepatitis C." post="This drug can prevent the fusion of the virus"/>
  <result pre="neuraminidase inhibitor (NAIs) used to treat influenza A and B" exact="infections" post="and reduces the mortality of patients, especially those admitted"/>
  <result pre="proliferation of influenza viruses in a doseâ€�dependent manner and prevents" exact="epithelial" post="barrier dysfunction and cytotoxicity for up to 4 days."/>
  <result pre="to when the drug was used before the onset of" exact="respiratory" post="failure (75â€‰mg oral dose twice daily; Adisasmito et al.,Â"/>
  <result pre="use is 5 days, but in people with influenza and" exact="acute" post="respiratory distress syndrome (ARDS), pneumonia or immune deficiency, the"/>
  <result pre="is 5 days, but in people with influenza and acute" exact="respiratory" post="distress syndrome (ARDS), pneumonia or immune deficiency, the drug"/>
  <result pre="days, but in people with influenza and acute respiratory distress" exact="syndrome" post="(ARDS), pneumonia or immune deficiency, the drug duration can"/>
  <result pre="in people with influenza and acute respiratory distress syndrome (ARDS)," exact="pneumonia" post="or immune deficiency, the drug duration can be increased"/>
  <result pre="guanosine nucleoside analog and antiviral compound used to treat various" exact="viral" post="infections, such as RSV, hepatitis C virus, bunyavirus, herpesvirus,"/>
  <result pre="compound used to treat various viral infections, such as RSV," exact="hepatitis C" post="virus, bunyavirus, herpesvirus, adenovirus, poxvirus, and some viral hemorrhagic"/>
  <result pre="RSV, hepatitis C virus, bunyavirus, herpesvirus, adenovirus, poxvirus, and some" exact="viral" post="hemorrhagic fevers. Ribavirin was first used in 1980 to"/>
  <result pre="immune responses. Ribavirin is an inhibitor of RNA synthesis by" exact="viral" post="RdRp as well as an inhibitor of mRNA capping"/>
  <result pre="patients it was different, however, ribavirin lowers hemoglobin concentrations in" exact="respiratory" post="patients and therefore reduces its potential as an antiviral"/>
  <result pre="and they further stimulate cytokine release and immune responses, reducing" exact="viral" post="replication, modulating host response, and improving clinical outcomes. Studies"/>
  <result pre="play an important role in protecting mice from the fatal" exact="infection" post="of wildâ€�type and oseltamivirâ€�resistantâ€�influenza B viruses. Favipiravir has also"/>
  <result pre="been used in combination with zanamivir to successfully clear the" exact="type B" post="influenza virus in immunocompromised children (Lumby et al.,Â 2020)."/>
  <result pre="clinical recovery over 7 days and reduced fever, cough, and" exact="respiratory" post="problems, it was therefore used as an effective drug"/>
  <result pre="coronavirus patients. Corticosteroids are widely used to treat severe communityâ€�acquired" exact="pneumonia" post="to prevent lung damage because they have suppressive effects"/>
  <result pre="lung damage because they have suppressive effects of severe and" exact="systemic" post="inflammation. But numerous studies show evidence of the ineffectiveness"/>
  <result pre="studies show evidence of the ineffectiveness of corticosteroid treatment on" exact="viral pneumonia" post="such as SARSâ€�CoV, MERSâ€�CoV, and H1N1 virus. Longâ€�term administration"/>
  <result pre="show evidence of the ineffectiveness of corticosteroid treatment on viral" exact="pneumonia" post="such as SARSâ€�CoV, MERSâ€�CoV, and H1N1 virus. Longâ€�term administration"/>
  <result pre="doses of corticosteroids do not reduce the mortality caused by" exact="septic shock" post="following primary pulmonary infection; but it can also have"/>
  <result pre="do not reduce the mortality caused by septic shock following" exact="primary" post="pulmonary infection; but it can also have benefits, such"/>
  <result pre="not reduce the mortality caused by septic shock following primary" exact="pulmonary" post="infection; but it can also have benefits, such as"/>
  <result pre="2017). Corticosteroid therapy for severe patients with ARDS can reduce" exact="pulmonary" post="fibrosis and prevent the progression of serious pathological conditions;"/>
  <result pre="performed following the guidelines recommended for patients with novel coronavirus" exact="pneumonia" post="(NCP) who have specific clinical symptoms, such as ARDS"/>
  <result pre="(NCP) who have specific clinical symptoms, such as ARDS or" exact="septic shock" post="Systematic corticosteroids treatment in the first 3â€&quot;5 days could"/>
  <result pre="has symptoms such as moderate or severe ARDS, sepsis, or" exact="septic shock" post="until used following recommended WHO clinical guidelines. Corticosteroids are"/>
  <result pre="in lymphocytes and an immunosuppressant in transplantation and treatment of" exact="autoimmune diseases" post="(Diamond, Zachariah, &amp;amp; Harris,Â 2002; Padalko et al.,Â 2003)."/>
  <result pre="et al.,Â 2003). It has also been shown to inhibit" exact="hepatitis" post="B and hepatitis C virus replication in combination with"/>
  <result pre="It has also been shown to inhibit hepatitis B and" exact="hepatitis C" post="virus replication in combination with IFNâ€�Î± and cyclosporine A."/>
  <result pre="patients using this drug combination could survive but patients had" exact="lower" post="acute physiology and chronic health (Allison &amp;amp; Eugui,Â 1993)."/>
  <result pre="using this drug combination could survive but patients had lower" exact="acute" post="physiology and chronic health (Allison &amp;amp; Eugui,Â 1993). MPA"/>
  <result pre="combination could survive but patients had lower acute physiology and" exact="chronic" post="health (Allison &amp;amp; Eugui,Â 1993). MPA also had a"/>
  <result pre="in the lungs and its expression has been reported in" exact="Type 2" post="pneumocytes (Hamming et al.,Â 2004). The extracellular domain of"/>
  <result pre="novel biological treatment to counter or limit the progression of" exact="infection" post="caused by coronaviruses that use ACE2 as a receptor"/>
  <result pre="as its proliferation in infected individuals (Batlle et al.,Â 2020)." exact="Viral" post="replication in the presence of ACE2 the most efficient"/>
  <result pre="the RAS to protect the lung from damage through weakening" exact="viral" post="entry into cells also a viral expansion to protect"/>
  <result pre="from damage through weakening viral entry into cells also a" exact="viral" post="expansion to protect the lung from injury. ACE2, fused"/>
  <result pre="Fc domain, providing a neutralizing antibody help to avoid any" exact="viral" post="escape, while also recruit the immune system to shape"/>
  <result pre="2020). 3 CONCLUSION 2019â€�nCoV outbreak from Wuhan, China offered a" exact="respiratory" post="viral pandemic that currently there are no effective therapies"/>
  <result pre="3 CONCLUSION 2019â€�nCoV outbreak from Wuhan, China offered a respiratory" exact="viral" post="pandemic that currently there are no effective therapies for"/>
  <result pre="this reason, vaccine research should be pursued intensely, until the" exact="infection" post="can be controlled with a protective vaccine to prevent"/>
  <result pre="has symptoms such as moderate or severe ARDS, sepsis or" exact="septic shock." post="MPA also has no effective inhibitory effect on SARSâ€�CoV,"/>
  <result pre="associated with side effects such as digestive adverse effects and" exact="hypokalemia" post="that should be considered by physicians. The use of"/>
  <result pre="regimen and betterâ€�stimulated cytokine release and inflammatory responses, and decreased" exact="viral" post="replication, modulated host response, and improved clinical outcomes. Ribavirin"/>
  <result pre="to the virus is also a good way of targeting" exact="viral" post="damage by targeting a cellular protein. CONFLICT OF INTERESTS"/>
  <result pre="infections: Analysis of a global patient registry. The Journal of" exact="Infectious" post="Diseases, 202(8), 1154â€&quot;1160.20831384 Allison, A. C., &amp;amp; Eugui, E."/>
  <result pre="effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil." exact="Immunological" post="Reviews, 136(1), 5â€&quot;28.7907572 Andrews, N. (2006). The fluâ€¦and you."/>
  <result pre="(2018). Corticosteroid therapy for critically ill patients with Middle East" exact="respiratory" post="syndrome. American Journal of Respiratory and Critical Care Medicine,"/>
  <result pre="therapy for critically ill patients with Middle East respiratory syndrome." exact="American" post="Journal of Respiratory and Critical Care Medicine, 197(6), 757â€&quot;767.29161116"/>
  <result pre="ill patients with Middle East respiratory syndrome. American Journal of" exact="Respiratory" post="and Critical Care Medicine, 197(6), 757â€&quot;767.29161116 Arabi, Y. M.,"/>
  <result pre="interferon on the outcome of critically Ill patients with MERS." exact="Viral" post="Respiratory Infections, 195, A6067. Batlle, D., Wysocki, J., &amp;amp;"/>
  <result pre="on the outcome of critically Ill patients with MERS. Viral" exact="Respiratory" post="Infections, 195, A6067. Batlle, D., Wysocki, J., &amp;amp; Satchell,"/>
  <result pre="(2020). Soluble angiotensinâ€�converting enzyme 2: A potential approach for coronavirus" exact="infection" post="therapy?Clinical Science, 134(5), 543â€&quot;545.32167153 Behillil, S., May, F., Fourati,"/>
  <result pre="N. (2019). Oseltamivir resistance in severe influenza A (H1N1) pdm09" exact="pneumonia" post="and acute respiratory distress syndrome: A French multicenter observational"/>
  <result pre="Oseltamivir resistance in severe influenza A (H1N1) pdm09 pneumonia and" exact="acute" post="respiratory distress syndrome: A French multicenter observational cohort study."/>
  <result pre="resistance in severe influenza A (H1N1) pdm09 pneumonia and acute" exact="respiratory" post="distress syndrome: A French multicenter observational cohort study. Clinical"/>
  <result pre="respiratory distress syndrome: A French multicenter observational cohort study. Clinical" exact="Infectious" post="Diseases, ciz90410.1093/cid/ciz90431538643 Boriskin, Y., Leneva, I., Pecheur, E.â€�I., &amp;amp;"/>
  <result pre="Polyak, S. (2008). Arbidol: A broadâ€�spectrum antiviral compound that blocks" exact="viral" post="fusion. Current Medicinal Chemistry, 15(10), 997â€&quot;1005.18393857 Brown, A. J.,"/>
  <result pre="K. Y. (2013). Broadâ€�spectrum antivirals for the emerging Middle East" exact="respiratory" post="syndrome coronavirus. Journal of Infection, 67(6), 606â€&quot;616.24096239 Chen, C.,"/>
  <result pre="Y. (2013). Broadâ€�spectrum antivirals for the emerging Middle East respiratory" exact="syndrome" post="coronavirus. Journal of Infection, 67(6), 606â€&quot;616.24096239 Chen, C., Zhang,"/>
  <result pre="Arbidol combined with LPV/r versus LPV/r alone against corona virus" exact="disease" post="2019: A retrospective cohort study. Journal of Infection. Advance"/>
  <result pre="Zachariah, M., &amp;amp; Harris, E. (2002). Mycophenolic acid inhibits dengue" exact="virus infection" post="by preventing replication of viral RNA. Virology, 304(2), 211â€&quot;221.12504563"/>
  <result pre="M., &amp;amp; Harris, E. (2002). Mycophenolic acid inhibits dengue virus" exact="infection" post="by preventing replication of viral RNA. Virology, 304(2), 211â€&quot;221.12504563"/>
  <result pre="Mycophenolic acid inhibits dengue virus infection by preventing replication of" exact="viral" post="RNA. Virology, 304(2), 211â€&quot;221.12504563 Falzarano, D., De Wit, E.,"/>
  <result pre="Nakamura, T. (2017). Favipiravir (Tâ€�705), a broad spectrum inhibitor of" exact="viral" post="RNA polymerase. Proceedings of the Japan Academy, Series B"/>
  <result pre="&amp;amp; Van der Laan, L. J. (2006). Mycophenolic acid inhibits" exact="hepatitis C" post="virus replication and acts in synergy with cyclosporin A"/>
  <result pre="1452â€&quot;1462.17101321 Holmes, E. C. (2013). What can we predict about" exact="viral" post="evolution and emergence?Current Opinion in Virology, 3(2), 180â€&quot;184.23273851 Hurst,"/>
  <result pre="Baloxavir Marboxil in highâ€�risk influenza patients (CAPSTONEâ€�2 study). Open Forum" exact="Infectious" post="Disease, 5(Suppl. 1), S764â€&quot;S765. Jiang, S., Liu, T., Hu,"/>
  <result pre="of arbidol and its derivatives against the pathogen of severe" exact="acute" post="respiratory syndrome in the cell cultures. Voprosy Virusologii, 53(4),"/>
  <result pre="arbidol and its derivatives against the pathogen of severe acute" exact="respiratory" post="syndrome in the cell cultures. Voprosy Virusologii, 53(4), 9â€&quot;13."/>
  <result pre="and its derivatives against the pathogen of severe acute respiratory" exact="syndrome" post="in the cell cultures. Voprosy Virusologii, 53(4), 9â€&quot;13. Kruse,"/>
  <result pre="of the index patient who caused tertiary transmission of Coronavirus" exact="disease" post="2019 in Korea: The application of lopinavir/ritonavir for the"/>
  <result pre="Korea: The application of lopinavir/ritonavir for the treatment of COVIDâ€�19" exact="pneumonia" post="monitored by quantitative RTâ€�PCR. Journal of Korean Medical Science,"/>
  <result pre="may predict the outcome of COVIDâ€�19 progression. International Journal of" exact="Infectious" post="Diseases, 95, 183â€&quot;191.32173576 Lo, M. K., Jordan, R., Arvey,"/>
  <result pre="Shah, D., â€¦ Breuer, J. (2020). Favipiravir and zanamivir cleared" exact="infection" post="with influenza B in a severely immunocompromised child. Clinical"/>
  <result pre="infection with influenza B in a severely immunocompromised child. Clinical" exact="Infectious" post="Diseases, ciaa023.32124919 Markland, W., McQuaid, T., Jain, J., &amp;amp;"/>
  <result pre="Martinez, M. A. (2020). Compounds with therapeutic potential against novel" exact="respiratory" post="2019 coronavirus. Antimicrobial Agents and Chemotherapy, 64, 00399â€�20. Mulangu,"/>
  <result pre="Study Team (2019). A randomized, controlled trial of Ebola virus" exact="disease" post="therapeutics. New England Journal of Medicine, 381(24), 2293â€&quot;2303.31774950 Ning,"/>
  <result pre="J. (2003). Mycophenolate mofetil inhibits the development of Coxsackie B3â€�virusâ€�induced" exact="myocarditis" post="in mice. BMC Microbiology, 3(1), 25.14687413 Pedersen, N. C.,"/>
  <result pre="analog GSâ€�441524 for treatment of cats with naturally occurring feline" exact="infectious" post="peritonitis. Journal of Feline Medicine and Surgery, 21(4), 271â€&quot;281.30755068"/>
  <result pre="New insights into the antiviral effects of chloroquine. The Lancet" exact="Infectious" post="Diseases, 6(2), 67â€&quot;69.16439323 Sheahan, T., Sims, A., Graham, R.,"/>
  <result pre="novel coronavirus: Implication for development of RBD protein as a" exact="viral" post="attachment inhibitor and vaccine. Cellular &amp;amp; Molecular Immunology, 1â€&quot;8."/>
  <result pre="(2018). An evaluation of chloroquine as a broadâ€�acting antiviral against" exact="hand, foot and mouth disease." post="Antiviral Research, 149, 143â€&quot;149.29175128 Tian, S., Hu, W., Niu,"/>
  <result pre="Niu, L., Liu, H., Xu, H., &amp;amp; Xiao, S.â€�Y. (2020)." exact="Pulmonary" post="pathology of early phase 2019 novel coronavirus (COVIDâ€�19) pneumonia"/>
  <result pre="(2020). Pulmonary pathology of early phase 2019 novel coronavirus (COVIDâ€�19)" exact="pneumonia" post="in two patients with lung cancer. Journal of Thoracic"/>
  <result pre="phase 2019 novel coronavirus (COVIDâ€�19) pneumonia in two patients with" exact="lung cancer." post="Journal of Thoracic Oncology, 15(5), 700â€&quot;704.32114094 Uyeki, T. M.,"/>
  <result pre="(COVIDâ€�19) pneumonia in two patients with lung cancer. Journal of" exact="Thoracic" post="Oncology, 15(5), 700â€&quot;704.32114094 Uyeki, T. M., Bernstein, H. H.,"/>
  <result pre="â€¦ Pavia, A. T. (2019). Clinical practice guidelines by the" exact="Infectious" post="Diseases Society of America: 2018 update on diagnosis, treatment,"/>
  <result pre="Pavia, A. T. (2019). Clinical practice guidelines by the Infectious" exact="Diseases" post="Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis,"/>
  <result pre="treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clinical" exact="Infectious" post="Diseases, 68(6), e1â€&quot;e47. Wan, Y., Shang, J., Graham, R.,"/>
  <result pre="C. (2013). Antiâ€�malaria drug chloroquine is highly effective in treating" exact="avian influenza" post="A H5N1 virus infection in an animal model. Cell"/>
  <result pre="chloroquine is highly effective in treating avian influenza A H5N1" exact="virus infection" post="in an animal model. Cell Research, 23(2), 300â€&quot;302.23208422 Yang,"/>
  <result pre="is highly effective in treating avian influenza A H5N1 virus" exact="infection" post="in an animal model. Cell Research, 23(2), 300â€&quot;302.23208422 Yang,"/>
  <result pre="bat coronavirus closely related to the direct progenitor of severe" exact="acute" post="respiratory syndrome coronavirus. Journal of Virology, 90(6), 3253â€&quot;3256. Zhang,"/>
  <result pre="coronavirus closely related to the direct progenitor of severe acute" exact="respiratory" post="syndrome coronavirus. Journal of Virology, 90(6), 3253â€&quot;3256. Zhang, H.,"/>
  <result pre="closely related to the direct progenitor of severe acute respiratory" exact="syndrome" post="coronavirus. Journal of Virology, 90(6), 3253â€&quot;3256. Zhang, H., Wang,"/>
 </snippets>
</snippetsTree>
